US Broker Ratings

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Evaluating a 219.73% Potential Upside in Biotech Innovation

Viking Therapeutics, Inc. (NASDAQ: VKTX) has garnered significant attention in the biotech sector, thanks to its robust pipeline of innovative drug candidates and an impressive potential..

Investor Outlook: Galapagos NV (GLPG) Faces Challenges Amidst Potential Downside

Galapagos NV (NASDAQ: GLPG), a biotechnology firm hailing from Belgium, is capturing investor attention not only for its innovative medical advancements but also for the financial..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 83% Upside Potential Awaits in Revolutionary Medical Devices

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is making waves in the healthcare sector with its innovative approach to urologic surgery. Specializing in surgical robotics, this San Jose-based..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Revenue Growth Soars as Analysts Eye 24.65% Upside

Alignment Healthcare, Inc. (ALHC), a key player in the healthcare plans industry, has been capturing investor attention with its remarkable revenue growth and a promising potential..

Premier, Inc. (PINC) Investor Outlook: Navigating A Challenging Healthcare Landscape with a Strong Dividend Yield

Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare improvement sector, offers a diverse array of solutions aimed at enhancing provider performance, optimizing supply chains,..

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring an 88.57% Upside Potential

GeneDx Holdings Corp. (NASDAQ: WGS) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of..

Scholar Rock Holding Corp. (SRRK) Stock Analysis: Biotech Innovator with Strong Buy Signals

Scholar Rock Holding Corporation (NASDAQ: SRRK) is a notable player in the biotechnology sector, engaging in pioneering work to develop treatments targeting serious diseases influenced by..

Warby Parker Inc. (WRBY) Stock Analysis: Evaluating a 21% Upside Potential

Warby Parker Inc. (NYSE: WRBY) stands out in the healthcare sector with its innovative approach to eyewear retail. As a prominent player in the medical instruments..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Powerhouse with 32% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is a standout player in the dynamic biotechnology sector, offering a diverse portfolio of licensed biopharmaceutical assets. Based in Jupiter, Florida,..

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 60% Potential Upside in the Healthcare Sector

Clover Health Investments, Corp (NASDAQ: CLOV) has been catching the attention of investors with its promising 60.07% potential upside, according to recent analyst ratings. Specializing in..

Concentra Group Holdings (CON): Analyst Ratings Signal 21% Upside in Healthcare Stock

For investors seeking opportunities within the healthcare sector, Concentra Group Holdings Parent (CON) offers an intriguing proposition. Headquartered in Addison, Texas, Concentra has carved out a..

Crinetics Pharmaceuticals, Inc. (CRNX): Investor Outlook with a 99% Potential Upside

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage biotech firm focused on pioneering treatments for rare endocrine diseases, is capturing the attention of savvy investors with a..

Addus HomeCare Corporation (ADUS) Stock Analysis: 23.9% Upside Potential Makes It a Compelling Buy

Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the healthcare sector, is drawing investor attention with its robust growth trajectory and promising analyst ratings. The..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Evaluating a 25% Upside Potential in the Biotech Sector

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a key player in the biotechnology sector, is capturing investor attention with its promising pipeline and notable potential for growth. With..

Denali Therapeutics Inc. (DNLI) Stock Analysis: A Potential 75% Upside in the Biotech Sector

Denali Therapeutics Inc. (NASDAQ: DNLI) stands out in the biotechnology sector with a market capitalization of $2.93 billion, focusing on developing therapeutics for neurodegenerative and lysosomal..

Veracyte, Inc. (VCYT) Stock Analysis: Unpacking a Potential 33% Upside for Investors

Veracyte, Inc. (VCYT), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, offers a compelling opportunity for investors seeking growth in..

Alvotech (ALVO): A 378% Upside Potential in the Biosimilar Market

Alvotech (ALVO), a prominent player in the healthcare sector specializing in the development and manufacturing of biosimilar medicines, presents a compelling investment opportunity with a staggering..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Navigating Growth in the Generic Drug Market

Investors with an eye on the healthcare sector might find Amneal Pharmaceuticals, Inc. (AMRX) a compelling prospect, especially as the company makes significant strides in the..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Potential in the Dental Market

Envista Holdings Corporation (NYSE: NVST) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Brea, California, Envista..

QuidelOrtho Corporation (QDEL): Analyzing Its 47% Potential Upside in the Medical Devices Sector

QuidelOrtho Corporation (NASDAQ: QDEL) is a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in San Diego, California, the company delivers..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds